CAS: 2058-52-8; 8-Chloro-6-(4-Methylpiperazin-1-yl)Benzo[b][1,4]Benzothiazepine

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号3159-04-4 2-氯二苯并[b,f]的[1,... | CAS号2770-11-8 4'-氯-2-氨基-二苯醚 | CAS号109-01-3 N-甲基哌嗪 | CAS号13745-88-5 2,11-dichloro-d... | CAS号37750-29-1 2-氨基-4'-氯二苯硫醚 | CAS号626-58-4 4-甲基哌啶 | CAS号30690-45-0 2-chlorodibenzo...

合成工艺路线路线简述

    📜2-氯-二苯并[b,F][1,4]硫氮杂环庚烷-11(10H)-酮置于n,N-二甲基苯胺,三氯氧磷体系中,用 Xylene 用作溶剂,化学反应 10.0H,反应生成氯噻平
    参考文献:在11-Stellung氨基取代基dibenzo [b,F]-1,4-Thiazepine和-Oxazepine中使用über.9. Mitteilungübersiebengliedrige杂环†
    标题:在11-Stellung氨基取代基dibenzo [b,F]-1,4-Thiazepine和-Oxazepine中使用über.9. Mitteilungübersiebengliedrige杂环†
    摘要:在11-氨基取代的二苯并[b,F]-1,4-噻氮平和二苯并[b,F]-1,4-氧杂氮平系列iii中发现了抗精神病药.它们可以通过亚氨基氯化物vi的氨解和/或尿素ii的bischler-Napieralski用pocl 3闭环合成.
    Doi:10.1002/hlca.19670500131

    海关参考信息

    专利信息


    专利号:US-9884844-B2
    优先权日:2012-12-31
    标 题:Heterocyclic compounds and methods of use thereof
    发明人:FANG QUN KEVIN; CAMPBELL UNA; SPEAR KERRY L
    权利人:SUNOVION PHARMACEUTICALS INC; SUNOVION PHARMACEUTICALS INC
    摘要:Provided herein are heterocyclyl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.

    专利号:US-2023241088-A1
    优先权日:2022-01-17
    标 题 :Composition for preventing or treating lung cancer comprising ortho-topolin riboside as active ingredient
    发明人:CHOI HYUNG-KYOON; LEE HWANHUI
    权利人:CHUNG ANG UNIV INDUSTRY ACADEMY COOPERATION FOUNDATION
    摘要:The present disclosure relates to a composition for preventing or treating lung cancer, including ortho topolin riboside (oTR) as an active ingredient, wherein oTR showed the highest cytotoxicity among all tested compounds against NSCLC cells, oTR reduced synthesis of amino acid and pyrimidine as well as glycolytic function in NSCLC cells and xenograft tumors.

    专利号:US-9670230-B2
    优先权日:2012-11-29
    标题 :Heteroaryl compounds and methods of use thereof
    发明人:CAMPBELL JOHN EMMERSON; JONES PHILIP
    权利人:SUNOVION PHARMACEUTICALS INC
    摘要:Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.

    专利号:US-11332462-B2
    优先权日:2012-02-08
    标 题 :Heteroaryl compounds and methods of use thereof
    发明人:CAMPBELL JOHN EMMERSON; CAMPBELL UNA; HANANIA TALEEN G; SHAO LIMING
    权利人:SUNOVION PHARMACEUTICALS INC; PGI DRUG DISCOVERY LLC
    摘要:Provided herein are thiophene compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.

    专利号:US-3150124-A
    优先权日:1962-03-16
    标题:Synthesis of kinetin glycosides
    发明人:GEORGE SVARNAS; HERMAN RUTNER
    权利人:GEORGE SVARNAS; HERMAN RUTNER

    专利号:WO-2025118034-A1
    优先权日:2023-12-06
    标题 :Compounds active at the serotonergic 5-ht2a receptor
    发明人:JORGENSON WILLIAM; TAN JINLONG; WHISH LACHLAN; BANISTER SAMUEL
    权利人:Psylo Pty Ltd
    摘要:The present disclosure relates to compounds of formula (I), their methods of synthesis, and their use in the treatment of mental illness or central nervous system disorders.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Mazhari S, Esmailian S, Shah-Esmaeili A, Goughari AS, Bazrafshan A, Zare M. Chlorpromazine versus clotiapine for schizophrenia. Cochrane Database Syst Rev. 2017 Apr 7;4:CD011810. doi: 10.1002/14651858.CD011810.pub2. Review. Dutch. doi: 10.1111/1556-4029.13261. Epub 2016 Dec 6. e1-2469.e2. doi: 10.1016/j.ajem.2016.06.059. Epub 2016 Jun 16. doi: 10.1111/1556-4029.12815. Epub 2015 Aug 10. pii: e001568. doi: 10.1161/JAHA.114.001568.
    7: Wang EH, Yang AC. Pisa syndrome after discontinuation of clotiapine in a patient with intractable insomnia. J Clin Psychopharmacol. 2014 Apr;34(2):276-7. doi: 10.1097/JCP.0000000000000045. doi: 10.1002/14651858.CD007726.pub2. Review. doi: 10.1002/14651858.CD000525.pub3. Review.
    11: Duran-Ferreras E, Duran-Ferreras A. [The usefulness of SPECT with 123I-ioflupane (DaTSCAN) in Parkinsonism induced by pharmaceuticals]. Rev Neurol. 2011 Mar 16;52(6):382-3. Spanish. doi: 10.1007/s10822-010-9407-8. Epub 2010 Dec 24. doi: 10.1016/j.jflm.2009.10.001. Epub 2009 Nov 28. Epub 2007 Jul 5. Epub 2005 Jan 26. Epub 2005 Aug 26. Review.

    合成参考文献


    摘要:Toxicology and Applied Pharmacology., 14(657), 1969
    摘要:Drugs in Japan, -(404), 1995
    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    参考文献:10.1186/1471-2431-11-40
    摘要:Clavenna A, Andretta M, Pilati P, Dusi M, Gangemi M, Gattoni MB, Lombardo G, Zoccante L, Mezzalira L, Bonati M. Antidepressant and antipsychotic use in an Italian pediatric population. BMC Pediatr. 2011 May 23;11():40.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知